Keith L Lee, MD
Urology · Palo Alto
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 1
- 1 carrier
- Office
- 1
Offices
1 location · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Looking this up.
Hospitals listed: Mills-Peninsula Medical Center · Sequoia Hospital. That is not proof they admit you there this week.
Plans that list them
1 plan · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Lee’s office at (415) 600-1020 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A75624 · Current
Licensed to practise in California · since 2001 · expires 2027-03-31 · University of California San Francisco School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Peninsula Medical CenterBurlingame, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.139, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.242, Oct 2024 – Sep 2025
- Sequoia HospitalRedwood City, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of CommonSpirit Health, which runs 145 hospitals in 19 statesPatients rate it 4 of 5 · 81% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Death rate among surgical inpatients with serious treatable complications: 104.12 (51.8 to 156.44) · 56 cases, Jul 2022 – Jun 2024Better than the national rate — Clostridium Difficile (C.Diff): 0, Oct 2024 – Sep 2025
See every measure and the patient survey for Peninsula Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.139 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.242 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.21 (0.27 to 2.15) · 1,258 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.81 (0.51 to 1.1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 155.44 (112.67 to 198.21) · 90 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.5 · 32 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 82 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10 · 188 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9 · 473 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.8 · 342 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.4 · 485 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 3,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.4) · 6,904 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,052 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.41 (1.43 to 5.39) · 1,695 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.72 (0.17 to 3.28) · 665 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,545 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.1 (1.3 to 12.9) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.96 (2.63 to 9.29) · 653 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.15 to 3.08) · 418 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.14 (0 to 0.78) · 5,539 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.7 · 192 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.215 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.263 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.74 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 300 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19 · 702 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 1.2 · 207 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -13.6 · 531 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 24.3 · 343 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.1 · 449 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.5 (2.8 to 7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.6 (6.7 to 13.7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.7 · 189 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11 · 45 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.6 · 117 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (9.7 to 17.2) · 584 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 764 cases | No different | Jan 2024 – Dec 2024 |
What patients said (523 patients answered, 27% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for Sequoia Hospital
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 1 better, 4 the same, 0 worse of 5 measures. Readmissions: 3 better, 6 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 104.12 (51.8 to 156.44) · 56 cases | Better | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.95 (0 to 1.98) · 472 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.91 (0.58 to 1.24) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.8 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.5 · 72 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.1 · 258 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.5 · 171 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.3 · 81 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.2 · 1,231 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.23 (0.01 to 0.44) · 3,018 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.03 to 0.44) · 3,164 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.59 (0.47 to 4.71) · 1,402 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.47 (0.04 to 2.9) · 926 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.68 (0.21 to 3.16) · 1,310 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.54 (4.42 to 14.67) · 978 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.98 (1.61 to 8.36) · 924 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.69 (0.19 to 3.19) · 192 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.57 (0 to 1.43) · 2,501 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.5 · 332 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.702 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.853 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.2 · 67 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.3 · 295 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -27.1 · 76 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -22.3 · 304 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -4.6 · 178 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.3 · 180 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 305 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.9 · 41 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.7 · 29 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.1 (9.7 to 17.7) · 129 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 713 cases | No different | Jan 2024 – Dec 2024 |
What patients said (631 patients answered, 27% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 78% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 82% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 81% |
| Doctors "always" treated them with courtesy and respect | 89% |
| Patients who gave a rating of "9" or "10" (high) | 77% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 77% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 55% |
| "YES", patients would definitely recommend the hospital | 81% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 91% |
Original Medicare doctor bills
$242,588
Medicare paid this office $242,588 for 718 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 522 | $88,687 | $113 |
| Diagnostic exam of bladder and urethra using an endoscope | 90 | $31,860 | $247 |
| New patient visit (45+ min) | 152 | $21,189 | $139 |
| Long return visit (40+ min) | 72 | $16,895 | $164 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 536 | $10,735 | $15 |
See all 17 services
| Return visit (30+ min) | 522 | $88,687 | $113 |
| Diagnostic exam of bladder and urethra using an endoscope | 90 | $31,860 | $247 |
| New patient visit (45+ min) | 152 | $21,189 | $139 |
| Long return visit (40+ min) | 72 | $16,895 | $164 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 536 | $10,735 | $15 |
| Waterjet destruction of prostrate accessed through the urethra | 16 | $10,110 | $632 |
| Ultrasound scan of pelvic region through rectum | 38 | $5,720 | $143 |
| Crushing of stone of ureter with insertion of stent using an endoscope | 12 | $5,265 | $376 |
| Ultrasound measurement of bladder capacity after voiding | 273 | $4,077 | $12 |
| New patient visit (60+ min) | 19 | $3,950 | $208 |
| Biopsy of prostate gland | 14 | $2,950 | $211 |
| Short return visit (20+ min) | 25 | $2,402 | $60 |
| New patient visit (30+ min) | 11 | $1,005 | $91 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 14 | $610 | $44 |
| Automated urinalysis test | 187 | $508 | $2 |
| Simple timed assessment of bladder emptying | 33 | $494 | $13 |
| Imaging of urinary tract following injection of a contrast agent | 13 | $329 | $22 |
Procedures Medicare counted
| Prostate resection | 11 | More than 58% of doctors who do this |
| Removal of tissue | 1-10 | None |
Who their Medicare patients are
718 Original Medicare patients in 2024. Average age 77 · Women 16% · Also on Medicaid 6% · Health risk score 0.92. At or below the middle of the specialty; the typical urology clinician is at 1.36.
Conditions among them: High blood pressure 65% · Coronary heart disease 31% · Cancer 21% · Diabetes 20% · Atrial fibrillation 20% · Chronic kidney disease 19% · Heart failure 9% · Depression 9% · COPD 6% · Stroke 6% · Dementia 5%.
The office billed $1,048,191, Medicare allowed $321,677 and paid $242,588; for 2,897 services of 65 kinds; $3,994 of it was for drugs given in the office and $238,594 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 718 | 2,897 | 77 | 0.92 | $1,048,191 | $242,588 |
| 2023 | 755 | 2,411 | 77 | 1.02 | $1,089,753 | $263,660 |
| 2022 | 715 | 2,371 | 77 | 0.98 | $1,031,860 | $247,845 |
| 2021 | 730 | 2,635 | 77 | 1.01 | $1,058,327 | $269,547 |
| 2020 | 769 | 2,598 | 77 | 1.16 | $1,064,663 | $258,855 |
| 2019 | 686 | 3,824 | 76 | 1.08 | $1,006,744 | $225,423 |
| 2018 | 509 | 1,990 | 75 | 1.00 | $839,764 | $172,410 |
| 2017 | 544 | 2,226 | 75 | 1.08 | $910,647 | $192,169 |
| 2016 | 516 | 2,202 | 75 | 1.14 | $855,935 | $190,533 |
| 2015 | 481 | 2,024 | 75 | 1.05 | $805,591 | $179,959 |
| 2014 | 498 | 1,781 | 75 | 1.05 | $825,200 | $169,951 |
| 2013 | 441 | 1,585 | 74 | 0.96 | $817,982 | $160,602 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 19 services
| Return visit (30+ min) | 527 | $94,877 | $110 |
| Diagnostic exam of bladder and urethra using an endoscope | 105 | $35,931 | $246 |
| New patient visit (45+ min) | 188 | $26,719 | $142 |
| Waterjet destruction of prostrate accessed through the urethra | 18 | $11,623 | $646 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 11 | $10,267 | None |
| Long return visit (40+ min) | 45 | $10,192 | $170 |
| Insertion of lower leg neurostimulator electrode | 14 | $6,953 | $122 |
| Crushing of stone of ureter with insertion of stent using an endoscope | 16 | $6,180 | $364 |
| New patient visit (60+ min) | 25 | $4,713 | $189 |
| Short return visit (20+ min) | 49 | $4,675 | $73 |
| Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | 11 | $3,890 | $324 |
| Biopsy of prostate gland | 16 | $3,715 | $232 |
| Ultrasound measurement of bladder capacity after voiding | 277 | $3,683 | $11 |
| Ultrasound scan of pelvic region through rectum | 18 | $2,813 | $148 |
| Complicated insertion of bladder tube | 13 | $2,318 | $145 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 18 | $756 | $42 |
| Automated urinalysis test | 197 | $541 | $2 |
| Imaging of urinary tract following injection of a contrast agent | 12 | $294 | $23 |
| Injection, garamycin, gentamicin, up to 80 mg | 14 | $49 | None |
2022: 14 services
| Return visit (30+ min) | 482 | $82,155 | $110 |
| Diagnostic exam of bladder and urethra using an endoscope | 93 | $30,260 | $244 |
| New patient visit (45+ min) | 164 | $22,743 | $139 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 14 | $16,239 | None |
| Insertion of lower leg neurostimulator electrode | 29 | $15,788 | $124 |
| Long return visit (40+ min) | 39 | $6,720 | $164 |
| New patient visit (60+ min) | 26 | $4,751 | $183 |
| Short return visit (20+ min) | 45 | $3,870 | $76 |
| Ultrasound measurement of bladder capacity after voiding | 303 | $3,585 | $10 |
| Simple insertion of temporary bladder tube | 12 | $1,172 | $56 |
| Telephone medical discussion with physician, 11-20 minutes | 13 | $823 | $63 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 29 | $777 | $24 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 14 | $702 | $35 |
| Automated urinalysis test | 163 | $471 | $2 |
2021: 21 services
| Return visit (30+ min) | 443 | $74,884 | $112 |
| Insertion of lower leg neurostimulator electrode | 43 | $32,889 | $132 |
| Diagnostic exam of bladder and urethra using an endoscope | 87 | $31,387 | $240 |
| New patient visit (45+ min) | 204 | $29,728 | $146 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 13 | $12,261 | None |
| Short return visit (20+ min) | 67 | $6,073 | $78 |
| Long return visit (40+ min) | 39 | $6,053 | $151 |
| New patient visit (60+ min) | 20 | $4,074 | $204 |
| Ultrasound measurement of bladder capacity after voiding | 299 | $3,634 | $10 |
| Complicated insertion of bladder tube | 11 | $3,159 | $150 |
| Simple insertion of temporary bladder tube | 11 | $2,517 | $59 |
| Telephone medical discussion with physician, 11-20 minutes | 29 | $2,156 | $70 |
| Ultrasound scan of pelvic region through rectum | 13 | $1,922 | $148 |
| Telephone medical discussion with physician, 21-30 minutes | 17 | $1,849 | $92 |
| New patient visit (30+ min) | 11 | $1,034 | $94 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 13 | $694 | $35 |
| Automated urinalysis test | 162 | $477 | $2 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 14 | $325 | $23 |
| Injection of drug or substance under skin or into muscle | 17 | $282 | $14 |
| Manual urinalysis test with examination using microscope, automated | 67 | $228 | $3 |
| Injection, garamycin, gentamicin, up to 80 mg | 15 | $32 | None |
2020: 26 services
| Return visit (30+ min) | 351 | $42,539 | $96 |
| Diagnostic exam of bladder and urethra using an endoscope | 112 | $30,562 | $205 |
| New patient visit (45+ min) | 220 | $28,880 | $131 |
| Insertion of lower leg neurostimulator electrode | 26 | $15,508 | $130 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 13 | $14,486 | None |
| Short return visit (20+ min) | 176 | $13,657 | $62 |
| Tissue marker, implantable, any type, each | 13 | $12,068 | $366 |
| Extended patient service without direct patient contact, first hour | 78 | $7,858 | $101 |
| Long return visit (40+ min) | 34 | $4,778 | $133 |
| Biopsy of prostate gland | 21 | $4,738 | $226 |
| Telephone medical discussion with physician, 11-20 minutes | 58 | $4,646 | $70 |
| Telephone medical discussion with physician, 21-30 minutes | 37 | $4,538 | $103 |
| New patient visit (30+ min) | 57 | $4,498 | $79 |
| Complicated insertion of bladder tube | 20 | $4,290 | $138 |
| Simple insertion of temporary bladder tube | 20 | $3,719 | $62 |
| Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | 11 | $3,169 | $288 |
| Ultrasound scan of pelvic region through rectum | 21 | $3,071 | $140 |
| Ultrasound measurement of bladder capacity after voiding | 240 | $2,795 | $10 |
| Simple bladder irrigation and/or instillation | 15 | $2,250 | $68 |
| Placement of device in prostate for radiation therapy | 14 | $1,905 | $136 |
| Ultrasonic guidance for needle placement | 14 | $732 | $52 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 13 | $656 | $33 |
| Automated urinalysis test | 181 | $465 | $2 |
| Injection of drug or substance under skin or into muscle | 26 | $420 | $14 |
| Manual urinalysis test with examination using microscope, automated | 109 | $377 | $3 |
| Injection, garamycin, gentamicin, up to 80 mg | 27 | $48 | None |
2019: 24 services
| Return visit (30+ min) | 231 | $29,692 | $97 |
| New patient visit (45+ min) | 193 | $26,822 | $139 |
| Diagnostic exam of bladder and urethra using an endoscope | 98 | $22,686 | $176 |
| Insertion of lower leg neurostimulator electrode | 28 | $20,284 | $131 |
| Short return visit (20+ min) | 224 | $16,611 | $60 |
| New patient visit (30+ min) | 76 | $7,168 | $94 |
| Crushing of stone of ureter with insertion of stent using an endoscope | 15 | $6,209 | $365 |
| Biopsy of prostate gland | 21 | $5,209 | $248 |
| Instillation of anti-cancer drug into bladder | 13 | $4,337 | $80 |
| Ultrasound measurement of bladder capacity after voiding | 286 | $4,156 | $12 |
| Long return visit (40+ min) | 26 | $3,731 | $138 |
| Tissue marker, implantable, any type, each | 13 | $3,541 | $96 |
| Ultrasound scan of pelvic region through rectum | 24 | $3,352 | $129 |
| Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | 12 | $3,201 | $267 |
| Complicated insertion of bladder tube | 12 | $3,124 | $130 |
| Simple insertion of temporary bladder tube | 14 | $1,893 | $57 |
| Placement of device in prostate for radiation therapy | 13 | $1,610 | $124 |
| Extended patient service without direct patient contact, first hour | 13 | $1,247 | $96 |
| Automated urinalysis test | 215 | $755 | $2 |
| Ultrasonic guidance for needle placement | 13 | $614 | $47 |
| Injection of drug or substance under skin or into muscle | 23 | $479 | $17 |
| Imaging of urinary tract following injection of a contrast agent | 14 | $381 | $24 |
| Manual urinalysis test with examination using microscope, automated | 76 | $273 | $3 |
| Injection, garamycin, gentamicin, up to 80 mg | 19 | $35 | None |
2018: 18 services
| Diagnostic exam of bladder and urethra using an endoscope | 116 | $24,452 | $159 |
| Short return visit (20+ min) | 247 | $21,502 | $59 |
| New patient visit (45+ min) | 97 | $13,285 | $137 |
| Insertion of lower leg neurostimulator electrode | 21 | $12,893 | $130 |
| Return visit (30+ min) | 109 | $11,157 | $96 |
| New patient visit (30+ min) | 93 | $8,427 | $91 |
| Biopsy of prostate gland | 26 | $5,614 | $216 |
| Bcg (intravesical) per instillation | 12 | $4,219 | None |
| Ultrasound measurement of bladder capacity after voiding | 214 | $4,149 | $16 |
| Complicated insertion of bladder tube | 12 | $3,355 | $116 |
| Instillation of anti-cancer drug into bladder | 12 | $3,143 | $81 |
| Ultrasound scan of pelvic region through rectum | 26 | $2,553 | $98 |
| Long return visit (40+ min) | 18 | $2,445 | $129 |
| Automated urinalysis test | 191 | $650 | $3 |
| Injection of drug or substance under skin or into muscle | 24 | $613 | $20 |
| Imaging of urinary tract following injection of a contrast agent | 11 | $177 | $16 |
| Manual urinalysis test with examination using microscope, automated | 26 | $111 | $4 |
| Injection, garamycin, gentamicin, up to 80 mg | 22 | $29 | None |
2017: 22 services
| Short return visit (20+ min) | 271 | $25,397 | $61 |
| Diagnostic exam of bladder and urethra using an endoscope | 108 | $23,392 | $157 |
| New patient visit (45+ min) | 110 | $15,462 | $141 |
| Insertion of lower leg neurostimulator electrode | 22 | $13,313 | $131 |
| Return visit (30+ min) | 83 | $9,058 | $98 |
| New patient visit (30+ min) | 93 | $8,306 | $89 |
| Ultrasound measurement of bladder capacity after voiding | 222 | $5,137 | $19 |
| Bcg (intravesical) per instillation | 13 | $5,053 | None |
| Crushing of stone of ureter with insertion of stent using an endoscope | 12 | $4,825 | $402 |
| Biopsy of prostate gland | 19 | $4,502 | $237 |
| Instillation of anti-cancer drug into bladder | 13 | $4,264 | $85 |
| Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | 18 | $4,101 | $228 |
| Complicated insertion of bladder tube | 13 | $3,436 | $118 |
| Long return visit (40+ min) | 21 | $2,446 | $111 |
| Ultrasound scan of pelvic region through rectum | 26 | $2,438 | $94 |
| Ultrasonic guidance for needle placement | 20 | $1,325 | $58 |
| Simple bladder irrigation and/or instillation | 12 | $943 | $67 |
| Injection of drug or substance under skin or into muscle | 24 | $800 | $26 |
| Automated urinalysis test | 195 | $753 | $3 |
| Imaging of urinary tract following injection of a contrast agent | 15 | $321 | $16 |
| Manual urinalysis test with examination using microscope, automated | 59 | $256 | $4 |
| Injection, garamycin, gentamicin, up to 80 mg | 21 | $34 | None |
2016: 19 services
| Diagnostic exam of bladder and urethra using an endoscope | 104 | $29,789 | $192 |
| Short return visit (20+ min) | 285 | $29,695 | $61 |
| Insertion of lower leg neurostimulator electrode | 29 | $16,166 | $125 |
| New patient visit (45+ min) | 105 | $14,483 | $138 |
| Return visit (30+ min) | 74 | $7,980 | $93 |
| New patient visit (30+ min) | 81 | $7,531 | $93 |
| Complicated insertion of bladder tube | 13 | $5,610 | $122 |
| Ultrasound measurement of bladder capacity after voiding | 226 | $5,372 | $19 |
| Instillation of anti-cancer drug into bladder | 12 | $4,187 | $100 |
| Bcg (intravesical) per instillation | 11 | $4,128 | None |
| Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | 13 | $3,138 | $224 |
| Biopsy of prostate gland | 16 | $3,053 | $191 |
| Simple bladder irrigation and/or instillation | 13 | $2,659 | $81 |
| Long return visit (40+ min) | 19 | $2,429 | $128 |
| Ultrasound scan of pelvic region through rectum | 25 | $2,232 | $89 |
| Ultrasonic guidance for needle placement | 18 | $1,123 | $59 |
| Automated urinalysis test | 221 | $899 | $3 |
| Injection of drug or substance under skin or into muscle | 22 | $571 | $24 |
| Injection, garamycin, gentamicin, up to 80 mg | 21 | $22 | None |
2015: 19 services
| Diagnostic exam of bladder and urethra using an endoscope | 92 | $30,627 | $203 |
| Short return visit (20+ min) | 273 | $29,050 | $62 |
| New patient visit (45+ min) | 112 | $16,509 | $147 |
| Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope | 16 | $12,525 | $783 |
| Insertion of lower leg neurostimulator electrode | 17 | $9,303 | $129 |
| Complicated insertion of bladder tube | 20 | $6,811 | $126 |
| New patient visit (30+ min) | 66 | $6,361 | $96 |
| Return visit (30+ min) | 63 | $6,167 | $92 |
| Ultrasound measurement of bladder capacity after voiding | 204 | $5,245 | $19 |
| Instillation of anti-cancer drug into bladder | 13 | $4,275 | $104 |
| Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | 12 | $2,925 | $244 |
| Biopsy of prostate gland | 13 | $2,705 | $208 |
| Ultrasound scan of pelvic region through rectum | 26 | $2,411 | $93 |
| Ultrasonic guidance for needle placement | 15 | $949 | $56 |
| Automated urinalysis test | 151 | $558 | $3 |
| Injection of drug or substance under skin or into muscle | 11 | $331 | $25 |
| Urinalysis, manual test | 76 | $263 | $3 |
| Manual urinalysis test with examination using microscope, automated | 30 | $135 | $4 |
| Injection, garamycin, gentamicin, up to 80 mg | 11 | $13 | None |
2014: 21 services
| Short return visit (20+ min) | 266 | $29,362 | $62 |
| Diagnostic exam of bladder and urethra using an endoscope | 102 | $27,589 | $190 |
| New patient visit (45+ min) | 143 | $19,725 | $138 |
| Complicated insertion of bladder tube | 21 | $8,503 | $121 |
| Insertion of lower leg neurostimulator electrode | 12 | $7,706 | $122 |
| Return visit (30+ min) | 57 | $5,934 | $89 |
| Instillation of anti-cancer drug into bladder | 11 | $5,480 | $100 |
| New patient visit (30+ min) | 62 | $5,304 | $86 |
| Crushing of stone of ureter with insertion of stent using an endoscope | 14 | $4,803 | $343 |
| Ultrasound measurement of bladder capacity after voiding | 203 | $4,768 | $19 |
| Biopsy of prostate gland | 20 | $3,970 | $198 |
| Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | 17 | $3,883 | $228 |
| Ultrasound scan of pelvic region through rectum | 31 | $2,777 | $90 |
| Long return visit (40+ min) | 12 | $1,874 | $125 |
| Simple bladder irrigation and/or instillation | 26 | $1,740 | $51 |
| Ultrasonic guidance for needle placement | 20 | $1,438 | $72 |
| Insertion of stent in ureter using an endoscope | 12 | $998 | $71 |
| Imaging of urinary tract following injection of a contrast agent | 18 | $309 | $16 |
| Manual urinalysis test with examination using microscope, automated | 46 | $201 | $4 |
| Automated urinalysis test | 24 | $75 | $3 |
| Urinalysis, manual test | 12 | $41 | $3 |
2013: 16 services
| Diagnostic exam of bladder and urethra using an endoscope | 93 | $22,297 | $187 |
| Short return visit (20+ min) | 235 | $22,082 | $62 |
| New patient visit (45+ min) | 128 | $17,465 | $136 |
| Return visit (30+ min) | 65 | $7,251 | $88 |
| New patient visit (30+ min) | 64 | $5,918 | $92 |
| Ultrasonic guidance for needle placement | 25 | $5,753 | $213 |
| Biopsy of prostate gland | 25 | $4,948 | $198 |
| Ultrasound measurement of bladder capacity after voiding | 193 | $4,929 | $19 |
| Complicated insertion of bladder tube | 15 | $4,532 | $122 |
| Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | 13 | $3,182 | $227 |
| Simple bladder irrigation and/or instillation | 34 | $2,348 | $53 |
| Ultrasound scan of pelvic region through rectum | 33 | $2,281 | $69 |
| Simple insertion of temporary bladder tube | 11 | $1,552 | $65 |
| Insertion of stent in ureter using an endoscope | 15 | $1,534 | $85 |
| Manual urinalysis test with examination using microscope, automated | 32 | $155 | $4 |
| Injection, garamycin, gentamicin, up to 80 mg | 11 | $11 | None |
Medicaid work
$146 in 2023
Medicaid paid $146 for 15 billed services this clinician did in 2023, up to 15 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 15 | $146 |
| 2023 | 15 | 1 | 15 | $146 |
Drugs they prescribed that Part D paid
$136,334
Pharmacies billed $136,334 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 1% of their Part D prescriptions (13 of 2,821) in 2024. At or below the middle of the specialty; the typical urology clinician is at 2%.
2,717 generic and 104 brand-name prescriptions · $136,334 in drug cost · 266 antibiotic prescriptions to 139 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Myrbetriq | 79 | $60,061 | $760 |
| Finasteride | 955 | $16,537 | $17 |
| Tamsulosin | 837 | $15,515 | $19 |
| Oxybutynin Chloride Er | 121 | $4,379 | $36 |
| Methenamine Hippurate | 46 | $4,212 | $92 |
See all 22 drugs
| Myrbetriq | 79 | $60,061 | $760 |
| Finasteride | 955 | $16,537 | $17 |
| Tamsulosin | 837 | $15,515 | $19 |
| Oxybutynin Chloride Er | 121 | $4,379 | $36 |
| Methenamine Hippurate | 46 | $4,212 | $92 |
| Potassium Citrate Er | 33 | $3,696 | $112 |
| Alfuzosin Hcl Er | 107 | $2,156 | $20 |
| Dutasteride | 36 | $1,618 | $45 |
| Desmopressin Acetate | 16 | $1,554 | $97 |
| Cephalexin | 96 | $1,032 | $11 |
| Tadalafil | 45 | $1,016 | $23 |
| Terazosin | 34 | $866 | $25 |
| Nitrofurantoin | 16 | $774 | $48 |
| Oxybutynin Chloride | 17 | $731 | $43 |
| Doxazosin Mesylate | 28 | $720 | $26 |
| Nitrofurantoin Mono-Macro | 29 | $328 | $11 |
| Sulfamethoxazole-Trimethoprim | 82 | $297 | $4 |
| Allopurinol | 15 | $128 | $9 |
| Ketorolac Tromethamine | 13 | $128 | $10 |
| Levofloxacin | 19 | $118 | $6 |
| Ciprofloxacin | 19 | $82 | $4 |
| Hydrocodone-Acetaminophen | 12 | $54 | $4 |
Year by year
| 2024 | 2,821 | 678 | 1% (13) | 4% | $136,334 |
| 2023 | 2,819 | 684 | 1% (14) | None | $161,151 |
| 2022 | 2,610 | 628 | None | None | $152,692 |
| 2021 | 2,549 | 640 | 1% (19) | None | $153,667 |
| 2020 | 2,588 | 628 | 1% (28) | None | $142,585 |
| 2019 | 1,845 | 493 | 1% (19) | None | $92,738 |
| 2018 | 1,640 | 411 | 2% (26) | None | $99,657 |
| 2017 | 1,578 | 371 | 2% (25) | 7% | $91,606 |
| 2016 | 1,463 | 349 | 2% (35) | 6% | $69,693 |
| 2015 | 1,383 | 317 | 3% (45) | 12% | $77,596 |
| 2014 | 1,317 | 306 | 3% (38) | None | $75,621 |
| 2013 | 1,307 | 293 | 3% (39) | None | $66,950 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 22 drugs
| Myrbetriq | 92 | $70,863 | $770 |
| Tamsulosin | 825 | $21,330 | $26 |
| Finasteride | 927 | $19,032 | $21 |
| Methenamine Hippurate | 66 | $6,953 | $105 |
| Oxybutynin Chloride Er | 143 | $5,411 | $38 |
| Testosterone | 13 | $3,443 | $265 |
| Dutasteride | 45 | $3,104 | $69 |
| Potassium Citrate Er | 17 | $2,728 | $160 |
| Alfuzosin Hcl Er | 99 | $2,456 | $25 |
| Solifenacin | 16 | $1,572 | $98 |
| Tadalafil | 30 | $1,502 | $50 |
| Terazosin | 41 | $1,354 | $33 |
| Desmopressin Acetate | 16 | $1,184 | $74 |
| Cephalexin | 92 | $1,143 | $12 |
| Nitrofurantoin | 27 | $1,080 | $40 |
| Doxazosin Mesylate | 32 | $1,001 | $31 |
| Sulfamethoxazole-Trimethoprim | 103 | $630 | $6 |
| Nitrofurantoin Mono-Macro | 28 | $350 | $12 |
| Allopurinol | 15 | $215 | $14 |
| Levofloxacin | 21 | $127 | $6 |
| Ciprofloxacin | 20 | $79 | $4 |
| Hydrocodone-Acetaminophen | 12 | $58 | $5 |
2022: 24 drugs
| Myrbetriq | 58 | $60,673 | $1,046 |
| Finasteride | 803 | $16,449 | $20 |
| Tamsulosin | 767 | $16,241 | $21 |
| Oxybutynin Chloride Er | 181 | $8,678 | $48 |
| Methenamine Hippurate | 55 | $6,747 | $123 |
| Toviaz | 12 | $6,452 | $538 |
| Dutasteride | 46 | $3,946 | $86 |
| Potassium Citrate Er | 24 | $3,166 | $132 |
| Alfuzosin Hcl Er | 64 | $2,043 | $32 |
| Nitrofurantoin | 34 | $1,979 | $58 |
| Solifenacin | 21 | $1,771 | $84 |
| Silodosin | 14 | $1,601 | $114 |
| Cephalexin | 99 | $1,297 | $13 |
| Terazosin | 45 | $1,224 | $27 |
| Desmopressin Acetate | 18 | $1,173 | $65 |
| Estradiol | 11 | $904 | $82 |
| Doxazosin Mesylate | 28 | $835 | $30 |
| Tadalafil | 20 | $644 | $32 |
| Sulfamethoxazole-Trimethoprim | 89 | $499 | $6 |
| Nitrofurantoin Mono-Macro | 14 | $222 | $16 |
| Allopurinol | 14 | $204 | $15 |
| Ciprofloxacin | 17 | $98 | $6 |
| Levofloxacin | 18 | $66 | $4 |
| Hydrochlorothiazide | 13 | $13 | $1 |
2021: 25 drugs
| Myrbetriq | 60 | $60,146 | $1,002 |
| Finasteride | 727 | $18,844 | $26 |
| Tamsulosin | 739 | $14,389 | $19 |
| Oxybutynin Chloride Er | 217 | $7,486 | $34 |
| Methenamine Hippurate | 35 | $6,408 | $183 |
| Potassium Citrate Er | 26 | $5,567 | $214 |
| Nitrofurantoin | 40 | $2,418 | $60 |
| Alfuzosin Hcl Er | 63 | $2,326 | $37 |
| Dutasteride | 24 | $1,816 | $76 |
| Tadalafil | 29 | $1,815 | $63 |
| Solifenacin | 20 | $1,408 | $70 |
| Cephalexin | 114 | $1,309 | $11 |
| Renacidin | 14 | $986 | $70 |
| Terazosin | 34 | $974 | $29 |
| Bicalutamide | 26 | $769 | $30 |
| Oxybutynin Chloride | 12 | $617 | $51 |
| Sulfamethoxazole-Trimethoprim | 82 | $603 | $7 |
| Doxazosin Mesylate | 17 | $600 | $35 |
| Nitrofurantoin Mono-Macro | 22 | $463 | $21 |
| Allopurinol | 19 | $305 | $16 |
| Indapamide | 11 | $181 | $16 |
| Ciprofloxacin | 26 | $69 | $3 |
| Hydrocodone-Acetaminophen | 18 | $68 | $4 |
| Fluconazole | 12 | $32 | $3 |
| Hydrochlorothiazide | 13 | $15 | $1 |
2020: 29 drugs
| Myrbetriq | 49 | $43,495 | $888 |
| Finasteride | 689 | $16,585 | $24 |
| Tamsulosin | 696 | $13,286 | $19 |
| Oxybutynin Chloride Er | 202 | $10,085 | $50 |
| Toviaz | 16 | $9,410 | $588 |
| Potassium Citrate Er | 28 | $6,699 | $239 |
| Methenamine Hippurate | 51 | $6,086 | $119 |
| Dutasteride | 22 | $2,679 | $122 |
| Nitrofurantoin | 32 | $2,248 | $70 |
| Estradiol | 14 | $1,855 | $132 |
| Solifenacin | 20 | $1,749 | $87 |
| Alfuzosin Hcl Er | 38 | $1,447 | $38 |
| Cephalexin | 129 | $1,289 | $10 |
| Bicalutamide | 34 | $1,149 | $34 |
| Tadalafil | 13 | $1,118 | $86 |
| Nitrofurantoin Mono-Macro | 44 | $1,019 | $23 |
| Terazosin | 35 | $892 | $25 |
| Sulfamethoxazole-Trimethoprim | 109 | $684 | $6 |
| Testosterone Cypionate | 15 | $628 | $42 |
| Oxybutynin Chloride | 19 | $539 | $28 |
| Doxazosin Mesylate | 12 | $398 | $33 |
| Allopurinol | 24 | $273 | $11 |
| Ciprofloxacin | 58 | $215 | $4 |
| Alendronate | 11 | $164 | $15 |
| Hydrocodone-Acetaminophen | 27 | $140 | $5 |
| Indapamide | 12 | $125 | $10 |
| Levofloxacin | 26 | $116 | $4 |
| Fluconazole | 11 | $64 | $6 |
| Diazepam | 14 | $10 | $1 |
2019: 19 drugs
| Myrbetriq | 27 | $16,500 | $611 |
| Finasteride | 508 | $14,363 | $28 |
| Tamsulosin | 616 | $12,079 | $20 |
| Toviaz | 12 | $7,696 | $641 |
| Oxybutynin Chloride Er | 144 | $6,063 | $42 |
| Methenamine Hippurate | 44 | $3,870 | $88 |
| Potassium Citrate Er | 19 | $3,793 | $200 |
| Tadalafil | 21 | $2,409 | $115 |
| Nitrofurantoin | 19 | $990 | $52 |
| Alfuzosin Hcl Er | 24 | $936 | $39 |
| Cephalexin | 58 | $914 | $16 |
| Oxybutynin Chloride | 16 | $900 | $56 |
| Dutasteride | 20 | $766 | $38 |
| Terazosin | 30 | $643 | $21 |
| Sulfamethoxazole-Trimethoprim | 91 | $637 | $7 |
| Bicalutamide | 12 | $256 | $21 |
| Ciprofloxacin | 36 | $116 | $3 |
| Hydrocodone-Acetaminophen | 17 | $109 | $6 |
| Nitrofurantoin Mono-Macro | 11 | $102 | $9 |
2018: 19 drugs
| Myrbetriq | 28 | $17,563 | $627 |
| Tamsulosin | 575 | $14,243 | $25 |
| Finasteride | 460 | $10,452 | $23 |
| Vesicare | 15 | $9,954 | $664 |
| Oxybutynin Chloride Er | 136 | $6,670 | $49 |
| Potassium Citrate Er | 14 | $3,242 | $232 |
| Nitrofurantoin | 15 | $2,924 | $195 |
| Methenamine Hippurate | 16 | $1,322 | $83 |
| Dutasteride | 15 | $857 | $57 |
| Alfuzosin Hcl Er | 17 | $773 | $45 |
| Oxybutynin Chloride | 11 | $607 | $55 |
| Sulfamethoxazole-Trimethoprim | 55 | $578 | $11 |
| Terazosin | 33 | $518 | $16 |
| Cephalexin | 48 | $499 | $10 |
| Bicalutamide | 11 | $266 | $24 |
| Levofloxacin | 25 | $260 | $10 |
| Nitrofurantoin Mono-Macro | 13 | $199 | $15 |
| Hydrocodone-Acetaminophen | 24 | $134 | $6 |
| Ciprofloxacin | 24 | $98 | $4 |
2017: 16 drugs
| Tamsulosin | 488 | $13,689 | $28 |
| Myrbetriq | 26 | $12,050 | $463 |
| Vesicare | 22 | $9,832 | $447 |
| Finasteride | 468 | $9,564 | $20 |
| Oxybutynin Chloride Er | 170 | $6,960 | $41 |
| Nitrofurantoin | 17 | $2,513 | $148 |
| Dutasteride | 16 | $1,031 | $64 |
| Oxybutynin Chloride | 20 | $827 | $41 |
| Cephalexin | 51 | $471 | $9 |
| Terazosin | 40 | $413 | $10 |
| Sulfamethoxazole-Trimethoprim | 33 | $364 | $11 |
| Chlorthalidone | 12 | $329 | $27 |
| Levofloxacin | 28 | $315 | $11 |
| Allopurinol | 17 | $260 | $15 |
| Hydrocodone-Acetaminophen | 25 | $122 | $5 |
| Ciprofloxacin | 11 | $100 | $9 |
2016: 15 drugs
| Tamsulosin | 412 | $11,068 | $27 |
| Finasteride | 442 | $8,723 | $20 |
| Oxybutynin Chloride Er | 186 | $6,791 | $37 |
| Vesicare | 23 | $6,243 | $271 |
| Myrbetriq | 12 | $5,092 | $424 |
| Rapaflo | 11 | $2,710 | $246 |
| Trospium Chloride Er | 13 | $2,506 | $193 |
| Dutasteride | 27 | $1,589 | $59 |
| Terazosin | 45 | $782 | $17 |
| Sulfamethoxazole-Trimethoprim | 42 | $536 | $13 |
| Levofloxacin | 33 | $473 | $14 |
| Cephalexin | 58 | $471 | $8 |
| Hydrocodone-Acetaminophen | 31 | $324 | $10 |
| Alfuzosin Hcl Er | 12 | $166 | $14 |
| Ciprofloxacin | 12 | $80 | $7 |
2015: 13 drugs
| Tamsulosin | 399 | $12,048 | $30 |
| Avodart | 55 | $11,036 | $201 |
| Finasteride | 409 | $7,342 | $18 |
| Vesicare | 20 | $5,539 | $277 |
| Cialis | 11 | $4,234 | $385 |
| Oxybutynin Chloride Er | 83 | $4,005 | $48 |
| Nitrofurantoin | 24 | $817 | $34 |
| Terazosin | 36 | $467 | $13 |
| Cephalexin | 78 | $453 | $6 |
| Sulfamethoxazole-Trimethoprim | 42 | $365 | $9 |
| Levofloxacin | 21 | $317 | $15 |
| Hydrocodone-Acetaminophen | 42 | $260 | $6 |
| Ciprofloxacin | 23 | $125 | $5 |
2014: 12 drugs
| Vesicare | 52 | $14,442 | $278 |
| Avodart | 59 | $13,367 | $227 |
| Finasteride | 363 | $8,891 | $24 |
| Tamsulosin | 403 | $8,420 | $21 |
| Cialis | 13 | $3,796 | $292 |
| Nitrofurantoin | 46 | $1,646 | $36 |
| Oxybutynin Chloride Er | 25 | $1,569 | $63 |
| Cephalexin | 73 | $462 | $6 |
| Sulfamethoxazole-Trimethoprim | 52 | $390 | $8 |
| Hydrocodone-Acetaminophen | 38 | $302 | $8 |
| Oxybutynin Chloride | 12 | $276 | $23 |
| Ciprofloxacin | 30 | $164 | $5 |
2013: 13 drugs
| Finasteride | 431 | $14,018 | $33 |
| Vesicare | 48 | $13,442 | $280 |
| Avodart | 44 | $10,667 | $242 |
| Tamsulosin | 381 | $8,244 | $22 |
| Cialis | 16 | $3,334 | $208 |
| Nitrofurantoin | 66 | $2,680 | $41 |
| Oxybutynin Chloride Er | 20 | $1,172 | $59 |
| Cephalexin | 75 | $567 | $8 |
| Nitrofurantoin Mono-Macro | 12 | $392 | $33 |
| Ciprofloxacin | 44 | $314 | $7 |
| Sulfamethoxazole-Trimethoprim | 35 | $264 | $8 |
| Hydrocodone-Acetaminophen | 37 | $189 | $5 |
| Allopurinol | 12 | $48 | $4 |
Money from drug and device companies
$262 in 2025
| 2025 | 4 | 4 | None | $262 |
| 2023 | 1 | 4 | $2,250 | $2,302 |
| 2022 | 3 | 4 | None | $263 |
| 2020 | 4 | 5 | None | $204 |
| 2019 | 2 | 3 | None | $147 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Boston Scientific | Spaceoar Vue System - 10ml | $159 | 1 payment
|
| Valencia Technologies | Ecoin Device Kit | $49 | 1 payment
|
| Lilly USA | Mounjaro | $28 | 1 payment
|
| Procept Biorobotics | Aquabeam Robotic System | $25 | 1 payment
|
See all 4 published payments
| Valencia Technologies | Meals · 2025-08-15 | Ecoin Device Kit | $49 |
| Lilly USA | Meals · 2025-05-05 | Mounjaro | $28 |
| Procept Biorobotics | Meals · 2025-04-17 | Aquabeam Robotic System | $25 |
| Boston Scientific | Meals · 2025-02-26 | Spaceoar Vue System - 10ml | $159 |
See earlier years (2023, 2022, 2020, 2019)
2023: $2,302
| PROCEPT BioRobotics | Aquabeam Robotic System | $2,302 | 4 payments
|
2022: $263
| PROCEPT BioRobotics | Aquabeam Robotic System | $190 | 2 payments
|
| Bayer HealthCare Pharmaceuticals | Nubeqa | $57 | 1 payment
|
| Medtronic | Signia | $16 | 1 payment
|
2020: $204
| Pfizer | Xtandi | $116 | 1 payment
|
| 180 Medical | Cure Catheter | $41 | 2 payments
|
| Boston Scientific | General - Kidney Stone Disease | $30 | 1 payment
|
| Allergan | Ubrelvy | $17 | 1 payment
|
2019: $147
| Intuitive Surgical | Da Vinci Surgical System | $116 | 1 payment
|
| Pfizer | Xtandi | $30 | 2 payments
|
Professional record
- NPI
- 1114036142
- Licence
- CA A75624California A75624: Current · expires 2027-03-31
- Trained
- University of California, San Francisco School of Medicine, 1999
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Urology (208800000X)
- Mailing address
- 325 Distel Cir, Los Altos, CA, 94022
- NPI first listed
- 2006-08-30
- NPI last updated
- 2020-05-26
- NPI record certified
- 2020-05-26
This is when the NPI record was last certified, not a medical board exam.